NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 0.2865
+0.0330 (13.02%)
Nov 3, 2026, 5:25 PM CET
NextCell Pharma AB Revenue
NextCell Pharma AB had revenue of 3.03M SEK in the quarter ending June 30, 2026, with 20.34% growth. This brings the company's total for the last twelve months to 10.60M, down -4.19% year-over-year. In the year 2025, NextCell Pharma AB had annual revenue of 13.96M with 26.17% growth. That makes NextCell Pharma AB the 43,470th largest company in the world by revenue and 668th in Sweden.
Revenue (ttm)
10.60M
Revenue Growth
-4.19%
P/S Ratio
3.36
Revenue / Employee
449.10K
Employees
24
Market Cap
36.21M
Revenue by Segment
Fiscal year ended Aug 31, 2025 See the full NextCell Pharma AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.96M | 2.90M | 26.17% |
| Aug 31, 2025 | 11.06M | -213.75K | -1.90% |
| Dec 31, 2024 | 11.28M | 1.00 | - |
| Aug 31, 2024 | 11.28M | -2.68M | -19.18% |
| Aug 31, 2023 | 13.96M | 7.73M | 124.03% |
| Aug 31, 2022 | 6.23M | 1.78M | 39.85% |
| Aug 31, 2021 | 4.45M | 287.92K | 6.91% |
| Aug 31, 2020 | 4.17M | 2.20M | 112.11% |
| Aug 31, 2019 | 1.96M | 1.31M | 199.68% |
| Aug 31, 2018 | 655.41K | 138.21K | 26.72% |
| Aug 31, 2017 | 517.20K | - | - |
| Aug 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 129.48M |
| ExpreS2ion Biotech Holding AB | 24.25M |
| Fluicell AB | 18.44M |
| AcouSort AB | 9.31M |
| OncoZenge AB | 5.97M |
| Spago Nanomedical AB | 3.81M |
| Pila Pharma AB | 275.74K |
| Aptahem AB | -537.00K |
NextCell Pharma AB News
- 2 months ago - NextCell Pharma AB Quarterly report: Q2 2026 - Filings
- 5 months ago - NextCell Pharma AB Quarterly report: Q1 2026 - Filings
- 8 months ago - NextCell Pharma AB Quarterly report: Transition period - Filings
- 11 months ago - NextCell Pharma AB Transcript: Life Science Summit 2025 - Transcripts
- 1 year ago - NextCell Pharma AB Quarterly report: Q4 2025 - Filings
- 1 year ago - NextCell Pharma AB Annual report: Q4 2025 - Filings